|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Accounts payable and accrued expenses | ||||
| Depreciation | ||||
| Change in fair value of SAFE notes | ||||
| Stock-based compensation | ||||
| Changes in operating assets and liabilities: | ||||
| Prepaid expenses | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Accrued compensation | ||||
| Net cash used in operating activities | ||||
| Cash flows from investing activities: | ||||
| Purchases of property and equipment | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities: | ||||
| Proceeds from exercise of restricted stock awards | ||||
| Proceeds from SAFE notes | ||||
| Proceeds from private placement | ||||
| Offering costs paid | ||||
| Payment of related party loan | ||||
| Proceeds from note payable - stockholder | ||||
| Net cash provided by financing activities | ||||
| Net change in cash | ||||
| Net increase in cash and cash equivalents | ||||
| Cash and cash equivalents, beginning of the year | ||||
| Cash and cash equivalents, end of the year | ||||
| Supplemental cash flow information: | ||||
| Subscription of SAFE notes | ||||
| Conversion of SAFE Notes into common stock | ||||
Loading...
